BioLineRx (BLRX) Tops Q2 EPS by 12c

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD66 at RBC Capital